SARS-CoV-2 NL63 Recombinant protein Liquid from Innovative Research has been recombinantly produced in E. coli. This is a Liquid protein buffered in Coronavirus NL63 protein solution is supplied in PBS. with a purity of >95% pure as determined by 10% PAGE (coomassie staining)..
More Details:
-
Species: SARS-CoV-2
-
Target:
-
Purity: >95% pure as determined by 10% PAGE (coomassie staining).
-
Source: E. coli
-
Storage Conditions: Store in working aliquots at -20°C; For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.
Additional Information:
Human coronavirus NL63 also known as HCoV-NL63 is a type of coronavirus that was identified in 2004. Among the associated diseases are mild to moderate upper respiratory tract infections, bronchiolitis, severe lower respiratory tract infection and croup. Coronavirus NL63 appears mainly in young children, the elderly and immunocompromised patients with acute respiratory illness. Coronavirus NL63 has a seasonal association in temperate climates. Coronavirus NL63 is not an emerging virus, but rather one that continually circulates the human population. Transmission of HCoV-NL63 is likely through droplet expulsion from the respiratory tract, which may be cotTages when close personal contact occurs. Coronavirus NL63 is able to endure for up to7 days in respiratory secretions and remains infective at room temperature. Once the virus has entered the host it binds to cellular receptors using spike proteins, similar to those found in HIV-1. Coronavirus NL63 is able to use Angiotensin-converting enzyme 2 (ACE2) as an entry receptor to target cells. Since coronavirus NL63 is a positive single-stranded RNA virus, the processes of replication via transcription and translation can be carried out in the cytoplasm of the infected cell.
. At Innovative Research we provide reliable, consistent products that deliver reliable, consistent results.
Powered by Bioz
